Nanjing Leads Biolabs Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Holding, Subsidiary
- Established
- 2012-11-27
- Employees
- 1
- Market Cap
- -
- Website
- http://leadsbiolabs.com
A Study to Assess LBL-007 in Combination With Toripalimab and Axitinib Tablets Subjects With Advanced Melanoma
Phase 1
Recruiting
- Conditions
- Advanced Melanoma
- Interventions
- First Posted Date
- 2020-11-23
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- Nanjing Leads Biolabs Co.,Ltd
- Target Recruit Count
- 88
- Registration Number
- NCT04640545
- Locations
- 🇨🇳
Beijing Cancer Hospital, Beijing, Beijing, China
🇨🇳Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, China
🇨🇳Hunan Cancer Hospital, Changsha, Hunan, China
© Copyright 2025. All Rights Reserved by MedPath